Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis

Published:2020-04 Issue:4 Volume:7 Page:344-353
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Hindley Guy,Beck Katherine,Borgan Faith,Ginestet Cedric E,McCutcheon Robert,Kleinloog Daniel,Ganesh Suhas,Radhakrishnan Rajiv,D'Souza Deepak Cyril,Howes Oliver D

Funder

Dana Foundation

Medical Research Council

Wellcome Trust

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference53 articles.

1. Association of state recreational marijuana laws with adolescent marijuana use;Cerdá;JAMA Pediatr,2017

2. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis;Black;Lancet Psychiatry,2019

3. Hashish and mental illness;Moreau,1973

4. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis;D'Souza;Neuropsychopharmacology,2004

5. Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study;Barkus;J Psychopharmacol,2011

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensuring safety in cannabinoid prescriptions: A call for critical assessment;European Neuropsychopharmacology;2024-10

2. Cannabidiol Alleviates Imiquimod-Induced Psoriasis by Inhibiting JAK2–STAT3 in a Mouse Model;Biomedicines;2024-09-12

3. From bench to bedside: the application of cannabidiol in glioma;Journal of Translational Medicine;2024-07-11

4. Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder;Expert Review of Neurotherapeutics;2024-06-25

5. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder;Schizophrenia Bulletin;2024-06-20